EACR 2026 - Speakers

Sheera Adar
The Adar Lab Israel
Salvador Aznar Benitah
Institute for Research in Biomedicine (IRB Barcelona) Spain
Alberto Bardelli
University of Torino / IFOM ETS Italy
Eduard Batlle
Institute for Research in Biomedicine (IRB Barcelona) Spain
Uri Ben-David
Tel Aviv University Israel
Yinon Ben-Neriah
The Hebrew University of Jerusalem Israel
Giulia Biffi
Cancer Research UK, Cambridge Institute United Kingdom
Gideon Bollag
Opna Bio USA
Giovanni Ciriello
University of Lausanne Switzerland
Alessio Ciulli
University of Dundee, Ciulli Lab United Kingdom
Johann de Bono
The Institute of Cancer Research, Drug Development Unit United Kingdom
Zoi Diamantopoulou
University of Glasgow United Kingdom
Mustafa Diken
BioNTech AG Germany
Caroline Dive
CRUK Cancer Biomarker Centre United Kingdom
Neta Erez
Tel Aviv University Israel
Keith Flaherty
Harvard University, Mass General Institute USA
Karuna Ganesh
The Karuna Ganesh Lab / Sloan Kettering Institute United States
Evangelos Giampazolias
University of Manchester United Kingdom
Vera Gorbunova
University of Rochester United States
Petra Hamerlik
The University of Manchester United Kingdom
Carl-Henrik Heldin
Uppsala University Sweden
Kairbaan Hodivala-Dilke
Barts Cancer Institute United Kingdom
Guillaume Jacquemet
Åbo Akademi University Finland
Camilla Jandus
Jandus Lab Switzerland
Phil Jones
Cambridge Stem Cell Institute United Kingdom
Johanna A Joyce
Ludwig Institute for Cancer Research Switzerland
Leeat Keren
Weizmann Institute of Science Israel
Guido Kroemer
The Kroemer Lab France
Bernhard Kuster
TUM School of Life Sciences Germany
Stefan Laufer
University of Tuebingen Germany
Anthony George Letai
Harvard University United States
Erez Levanon
The Goodman Faculty of Life Sciences Israel
Leanne Li
The Francis CRICK Institute United Kingdom
Xin Lu
University of Oxford United Kingdom
Marcos Malumbres
Spanish National Cancer Research Center (CNIO) Spain
Silvia Marsoni
Silvia Marsoni Lab Italy
Seamus J. Martin
Trinity College Dublin, The Martin Lab Ireland
Julie M. Mazet
Ludwig Cancer Research - Lausanne Branch - University of Lausanne Switzerland
Yifat Merbl
The Merbl Lab Israel
Christina Metoikidou
Netherlands Cancer Institute Netherlands
Péter Nagy
National Institute of Oncology Hungary
Renato Ostuni
IFOM-IEO Italy
Marina Pasca di Magliano
University of Michigan, Medical School United States
Attila Patócs
National Institute of Oncology Hungary
Daniel Peeper
Netherlands Cancer Institute Netherlands
Jonathon Pines
The Institute of Cancer Research, Pines Lab United Kingdom
Michael Platten
University of Heildelberg, Medical Faculty Mannheim Germany
Yuliya Pylayeva-Gupta
UNC School of Medicine United States
Timothy R. Rebbeck
Harvard T.H. Chan School of Public Health United States
Yardena Samuels
Weizmann Institute of Science Israel
Owen Sansom
School of Cancer Sciences United Kingdom
Stefano Santaguida
Santaguida Lab, University of Milan Italy
Victoria Sanz-Moreno
King's College London United Kingdom
Adrian Saurin
University of Dundee, School of Medicine United Kingdom
Christoph Scheiermann
University of Geneva Switzerland
Joan Seoane
VHIO, Seoane Lab Spain
Marisol S. Soengas
Spanish National Cancer Research Center (CNIO) Spain
Andreas Spitzmüller
AstraZeneca United Kingdom
Darrin Stuart
Novartis Switzerland
Zoltan Szallasi
Boston Children's Hospital United States
Tuomas Tammela
The Tuomas Tammela Lab United States
Li Tang
EPFL Switzerland
Chris Tape
University College London United Kingdom
Andreas Trumpp
HI-STEM GmbH in the German Cancer Research Center Germany
Jacco van Rheenen
Netherlands Cancer Institute Netherlands
Paolo Vineis
Imperial College, School of Public Health United Kingdom
Ashani T. Weeraratna
John Hopkins Bloomberg School of Public Health United States
Elisabete Weiderpass
International Agency for Research on Cancer (IARC) France
Sabine Werner
ETH Zurich Switzerland
Richard White
University of Oxford, Ludwig Institute for Cancer Research United Kingdom
Martha Zarou
The Francis Crick Institute United Kingdom
1